D.E. Shaw & Co’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.7M Buy
544,421
+74,136
+16% +$6.57M 0.03% 652
2025
Q4
$37.8M Buy
470,285
+315,947
+205% +$26.5M 0.02% 861
2025
Q3
$15.1M Buy
154,338
+76,085
+97% +$6.13M 0.01% 1380
2025
Q2
$5.45M Buy
78,253
+71,943
+1,140% +$4.1M ﹤0.01% 1970
2025
Q1
$313K Sell
6,310
-34,070
-84% -$2.15M ﹤0.01% 3744
2024
Q4
$2.82M Buy
40,380
+25,520
+172% +$2.12M ﹤0.01% 2455
2024
Q3
$1.56M Sell
14,860
-3,183
-18% -$372K ﹤0.01% 2907
2024
Q2
$2.57M Sell
18,043
-4,073
-18% -$470K ﹤0.01% 2426
2024
Q1
$2.47M Sell
22,116
-53,116
-71% -$6.33M ﹤0.01% 2464
2023
Q4
$9.76M Sell
75,232
-34,471
-31% -$4.75M 0.01% 1384
2023
Q3
$17.9M Buy
109,703
+41,193
+60% +$7.25M 0.02% 929
2023
Q2
$12.6M Buy
68,510
+18,221
+36% +$2.62M 0.01% 1157
2023
Q1
$6.7M Buy
50,289
+35,689
+244% +$4.19M 0.01% 1699
2022
Q4
$1.16M Sell
14,600
-4,184
-22% -$295K ﹤0.01% 3334
2022
Q3
$1.14M Buy
18,784
+7,590
+68% +$490K ﹤0.01% 3499
2022
Q2
$614K Sell
11,194
-2,720
-20% -$158K ﹤0.01% 3977
2022
Q1
$1.05M Buy
+13,914
New +$950K ﹤0.01% 3880
2021
Q4
Sell
-8,706
Closed -$409K 5344
2021
Q3
$409K Buy
+8,706
New +$379K ﹤0.01% 4197
2020
Q1
Sell
-45,626
Closed -$1.1M 3877
2019
Q4
$1.1M Sell
45,626
-102,395
-69% -$2.16M ﹤0.01% 2912
2019
Q3
$2.53M Buy
148,021
+21,082
+17% +$337K ﹤0.01% 2184
2019
Q2
$1.91M Buy
126,939
+95,487
+304% +$1.71M ﹤0.01% 2273
2019
Q1
$633K Buy
+31,452
New +$639K ﹤0.01% 2877
2017
Q4
Sell
-105,954
Closed -$2.9M 3550
2017
Q3
$2.9M Sell
105,954
-24,717
-19% -$547K ﹤0.01% 1766
2017
Q2
$2.74M Buy
130,671
+80,638
+161% +$1.7M ﹤0.01% 1775
2017
Q1
$941K Sell
50,033
-41,547
-45% -$654K ﹤0.01% 2332
2016
Q4
$1.33M Sell
91,580
-37,012
-29% -$504K ﹤0.01% 2287
2016
Q3
$1.71M Buy
128,592
+11,056
+9% +$128K ﹤0.01% 2036
2016
Q2
$1.26M Buy
117,536
+30,075
+34% +$323K ﹤0.01% 2261
2016
Q1
$979K Buy
87,461
+41,986
+92% +$429K ﹤0.01% 2368
2015
Q4
$471K Sell
45,475
-16,086
-26% -$171K ﹤0.01% 3126
2015
Q3
$658K Buy
61,561
+7,093
+13% +$86.4K ﹤0.01% 2884
2015
Q2
$644K Buy
54,468
+28,867
+113% +$334K ﹤0.01% 3012
2015
Q1
$244K Buy
25,601
+17,201
+205% +$178K ﹤0.01% 3378
2014
Q4
$86K Sell
8,400
-913
-10% -$7.92K ﹤0.01% 3915
2014
Q3
$74K Buy
9,313
+3,856
+71% +$29K ﹤0.01% 4005
2014
Q2
$44K Sell
5,457
-1,735
-24% -$12.9K ﹤0.01% 4110
2014
Q1
$62K Sell
7,192
-16,538
-70% -$152K ﹤0.01% 4196
2013
Q4
$232K Sell
23,730
-11
-0% -$100 ﹤0.01% 4197
2013
Q3
$200K Buy
23,741
+4,065
+21% +$32.9K ﹤0.01% 4091
2013
Q2
$143K Buy
+19,676
New +$114K ﹤0.01% 3824

Other funds holding ACLS

D.E. Shaw & Co's ACLS Position: Q1 2026 in Review

D.E. Shaw & Co increased its Axcelis (ACLS) stake by 16% in Q1 2026, buying an estimated $6.57M and bringing the position to 544,421 shares worth $50.7M. The position accounts for 0.03% of the portfolio, ranked #652.

D.E. Shaw & Co first reported a position in ACLS in Q2 2013 and has held it in 40 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • D.E. Shaw & Co held 544,421 shares of Axcelis worth $50.7M as of Q1 2026.
  • D.E. Shaw & Co bought 74,136 Axcelis shares in Q1 2026, an estimated $6.57M.
  • Axcelis made up 0.03% of D.E. Shaw & Co's portfolio in Q1 2026, its #652 holding.
  • D.E. Shaw & Co first reported a position in Axcelis in Q2 2013 and has held it in 40 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.